Related Experiment Videos
Hymenoptera sensitivity: diagnosis and treatment
1Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Allergy and Asthma Proceedings
|January 17, 2003
Summary
Hymenoptera venom immunotherapy (VIT) effectively prevents life-threatening anaphylaxis. This review covers diagnosing hymenoptera sensitivity, selecting patients for immunotherapy, and standard or modified VIT approaches.
Area of Science:
- Allergy and Immunology
- Toxicology
Background:
- Hymenoptera venom exposure causes anaphylaxis, leading to an estimated 50 annual deaths, potentially underestimated.
- Unrecognized anaphylaxis may be misdiagnosed as cardiac events or unexplained deaths in specific environments.
Purpose of the Study:
- To review the diagnosis and treatment of Hymenoptera sensitivity.
- To discuss patient selection criteria for venom immunotherapy (VIT).
- To cover standard VIT protocols and modified allergen approaches.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on Hymenoptera anaphylaxis and its management.
Main Results:
- Venom immunotherapy (VIT) is a highly effective treatment for preventing recurrent anaphylaxis.
- Early recognition and diagnosis are crucial for effective management.
Conclusions:
- VIT significantly reduces the risk of anaphylaxis in sensitized individuals.
- Comprehensive understanding of diagnosis, patient selection, and treatment options is essential for optimal patient outcomes.